SavedAdd your journal

Journals / Cukurova Medical Journal / 2017 / Cilt: 42 - Sayı: 2

Gray platelet syndrome

Gri trombosit sendromu

Fatima AYAZ
Saeed Bin AYAZ
Sunila TASHFEEN
Muhammad FURRUKH
Pages
360–362
Publication Date
2017-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present here report of a case who presented with repeated episodes of abnormal bleeding and was found to have GPS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gray platelet syndrome (GPS) is an autosomal recessive disorder characterized by thrombocytopenia and defective platelets that appear pale on light microscope.
📊
Key Findings & Data:Patients present with easy bruisability, nose bleeds, menorrhagia and prolonged bleeding.
💡
Conclusion & Impact:We present here report of a case who presented with repeated episodes of abnormal bleeding and was found to have GPS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Bleeding disorder · gray platelet syndrome · thrombocytopenia

Abstract

Gray platelet syndrome (GPS) is an autosomal recessive disorder characterized by thrombocytopenia and defective platelets that appear pale on light microscope. Patients present with easy bruisability, nose bleeds, menorrhagia and prolonged bleeding. There is no specific treatment for GPS and the management includes anticipating risks and preventing bleeding by avoiding drugs that impair platelet function. We present here report of a case who presented with repeated episodes of abnormal bleeding and was found to have GPS.

Özet

Gri trombosit (platelet) sendromu (GPS), trombositopeni ve ışık mikroskopunda soluk görünen kusurlu trombositlerle karakterize, otozomal resesif geçişli bir hastalıktır. Hastalarda kolay morarma, burun kanaması, menoraji ve uzun kanamalar görülmektedir. GPS için spesifik bir tedavi bulunmamaktadır dolayısı ile hastalığa karşı, riskleri öngörmek ve kanamanın önlenmesi için trombosit fonksiyonunu bozan ilaçlardan kaçınmak gerekmektedir. Bu olgu sunumunda, tekrarlayan anormal kanama atakları olan ve GPS bulgusu bulunan bir vaka sunulmaktadır.

🔖

Cite This Article

AYAZ, F., AYAZ, S. B., TASHFEEN, S., FURRUKH, M. (2017). Gray platelet syndrome. Cukurova Medical Journal, Cilt: 42 - Sayı: 2, 360–362. https://ajindex.com/articles/148606

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Raccuglia G. Gray platelet syndrome. A variety of qualitative platelet disorder. Am J Med. 1971;51:818-28
  2. Balduini CL, Iolascon A, Savoia A. Inherited thrombocytopenias: from genes to therapy. Haematologica. 2002;87:860-80
  3. Laffan M, Manning R. Investigation of haemostasis. In Practical Hematology, 10th ed (Eds Dacie JV, Lewis SM):429. Philadelphia, PA, Elsevier. 2006
  4. Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev. 2007;21:21-36
  5. Nurden AT, Nurden P. Inherited thrombocytopenias. Haematologica. 2007;92:1158-64
  6. Online Mendelian inheritance in man. http://omim.org (accessed 23 Oct 2015)
  7. Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions. Thromb Haemost. 2008;99:253-63
  8. Salles II, Feys HB, Iserbyt BF, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Inherited traits affecting platelet function. Blood Rev. 2008;22:155-72
  9. Drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood. 2004;103:390-8
  10. Laskey AL, Tobias JD; Anesthetic implications of the gray platelet syndrome. Can J Anaesth. 2000;47:1224-9
  11. Balduini CL, Iolascon A, Savoia A. Inherited thrombocytopenias: from genes to therapy. Haematologica. 2002;87:860-80
  12. Mannucci PM. Prophylaxis in congenital coagulation disorders: past, present and future. Blood Transfus. 2008;6:1-3.